Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Central venous-to-arterial carbon dioxide difference in the early postoperative care following liver transplantation.

Autor: Saez, I, Sáez, J, Talayero, M, González, N, Catalán, M, Sánchez Izquierdo, JÁ, Montejo, JC

Publikováno v: Intensive Care Medicine Experimental; Dec2015 Supplement, Vol. 3, p1-2, 2p

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function.

Autor: Bilbao-Meseguer I; Department of Pharmacy, Cruces University Hospital, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain., Barrasa H; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Asín-Prieto E; Inserm U1070: Pharmacologie des Anti-Infectieux, Pôle Biologie Santé, Université de Poitiers, Bâtiment B36, 1 Rue Georges Bonnet, 86022 Poitiers, France., Alarcia-Lacalle A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Rodríguez-Gascón A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Maynar J; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Sánchez-Izquierdo JÁ; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Balziskueta G; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Griffith MS; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Quilez Trasobares N; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Solinís MÁ; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Isla A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2021 Oct 15; Vol. 13 (10). Date of Electronic Publication: 2021 Oct 15.

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation.

Autor: Soraluce A; Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, Centro de Investigación Lascaray-ikergunea, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain., Barrasa H; Intensive Care Unit, Araba University Hospital, 01004 Vitoria-Gasteiz, Spain., Asín-Prieto E; Pharmacometrics & Systems Pharmacology Research Unit, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain., Sánchez-Izquierdo JÁ; Intensive Care Unit. Doce de Octubre University Hospital, 28041 Madrid, Spain., Maynar J; Intensive Care Unit, Araba University Hospital, 01004 Vitoria-Gasteiz, Spain., Isla A; Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, Centro de Investigación Lascaray-ikergunea, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain., Rodríguez-Gascón A; Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, Centro de Investigación Lascaray-ikergunea, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2020 Jan 09; Vol. 12 (1). Date of Electronic Publication: 2020 Jan 09.

[Continuous renal replacement therapies and antifungal drugs: an essential review].

Autor: Silva-Obregón JA, Benito-Puncel C, Borrallo-Pérez JM, Sánchez-Izquierdo JÁ

Publikováno v: Enfermedades infecciosas y microbiologia clinica [Enferm Infecc Microbiol Clin] 2012 Feb; Vol. 30 (2), pp. 110-1. Date of Electronic Publication: 2011 Oct 05.